Insider Transactions in Q1 2021 at Catalent, Inc. (CTLT)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 22
2021
|
Kay A Schmidt SVP, Enterprise Functions |
SELL
Open market or private sale
|
Direct |
1,400
-9.17%
|
$147,000
$105.77 P/Share
|
Mar 19
2021
|
John R Chiminski Executive Chair |
SELL
Open market or private sale
|
Direct |
183,024
-20.43%
|
$19,400,544
$106.32 P/Share
|
Mar 19
2021
|
John R Chiminski Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
183,024
+14.38%
|
$7,687,008
$42.44 P/Share
|
Mar 18
2021
|
John R Chiminski Executive Chair |
SELL
Open market or private sale
|
Direct |
42,220
-20.51%
|
$4,433,100
$105.16 P/Share
|
Mar 18
2021
|
John R Chiminski Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
42,220
+17.02%
|
$1,519,920
$36.02 P/Share
|
Mar 18
2021
|
Steven L Fasman EVP & Chief Admin Officer |
SELL
Open market or private sale
|
Direct |
21,647
-12.12%
|
$2,251,288
$104.6 P/Share
|
Mar 18
2021
|
Steven L Fasman EVP & Chief Admin Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,647
+10.63%
|
$844,233
$39.95 P/Share
|
Feb 16
2021
|
Wetteny Joseph SVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.36%
|
$620,000
$124.92 P/Share
|
Feb 16
2021
|
Wetteny Joseph SVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.37%
|
$245,000
$49.41 P/Share
|
Feb 08
2021
|
Wetteny Joseph SVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,604
-8.46%
|
$520,252
$113.73 P/Share
|
Jan 21
2021
|
Ricci S Whitlow President, CSS |
SELL
Open market or private sale
|
Direct |
692
-21.18%
|
$81,656
$118.85 P/Share
|
Jan 11
2021
|
Karen Flynn Director |
SELL
Open market or private sale
|
Direct |
2,478
-3.4%
|
$277,536
$112.32 P/Share
|
Jan 06
2021
|
Scott Gunther SVP, Quality & Reg. Affairs |
SELL
Open market or private sale
|
Direct |
61
-0.37%
|
$6,344
$104.78 P/Share
|
Jan 04
2021
|
Jonathan Arnold SVP, CCO & Div. Head BioP Del. |
SELL
Open market or private sale
|
Direct |
16
-0.04%
|
$1,664
$104.42 P/Share
|
Jan 04
2021
|
Steven L Fasman EVP & Chief Admin Officer |
SELL
Open market or private sale
|
Direct |
189
-0.26%
|
$19,656
$104.42 P/Share
|
Jan 04
2021
|
Karen Flynn Director |
SELL
Open market or private sale
|
Direct |
99
-0.27%
|
$10,296
$104.42 P/Share
|
Jan 04
2021
|
Aristippos Gennadios Group Pres. Pharma & Consumer |
SELL
Open market or private sale
|
Direct |
110
-0.21%
|
$11,440
$104.42 P/Share
|
Jan 04
2021
|
Michael J Grippo SVP, Strategy & Corp. Dev. |
SELL
Open market or private sale
|
Direct |
126
-0.73%
|
$13,104
$104.42 P/Share
|
Jan 04
2021
|
Scott Gunther SVP, Quality & Reg. Affairs |
SELL
Open market or private sale
|
Direct |
120
-0.72%
|
$12,480
$104.42 P/Share
|
Jan 04
2021
|
Wetteny Joseph SVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
172
-0.32%
|
$17,888
$104.42 P/Share
|
Jan 04
2021
|
Alessandro Maselli President & CEO |
SELL
Open market or private sale
|
Direct |
148
-0.75%
|
$15,392
$104.42 P/Share
|
Jan 04
2021
|
Ricardo Pravda Chief Transformation Officer |
SELL
Open market or private sale
|
Direct |
78
-0.56%
|
$8,112
$104.42 P/Share
|
Jan 04
2021
|
Kay A Schmidt SVP, Enterprise Functions |
SELL
Open market or private sale
|
Direct |
73
-0.48%
|
$7,592
$104.42 P/Share
|
Jan 04
2021
|
Ricci S Whitlow President, CSS |
SELL
Open market or private sale
|
Direct |
83
-2.48%
|
$8,632
$104.42 P/Share
|